Hyperbaric Oxygen Therapy Improves Parkinson’s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway

Hyperbaric oxygen therapy (HBOT) has been suggested as a potential adjunctive therapy for Parkinson’s disease (PD). PD is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The aim of this study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hung-Te, Yang, Ya-Lan, Chang, Wan-Hsuan, Fang, Wei-Yu, Huang, Shu-Hung, Chou, Shah-Hwa, Lo, Yi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138219/
https://www.ncbi.nlm.nih.gov/pubmed/35625589
http://dx.doi.org/10.3390/biom12050661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138219/
https://www.ncbi.nlm.nih.gov/pubmed/35625589
http://dx.doi.org/10.3390/biom12050661

Ejemplares similares